Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Mallinckrodt
UBS
Deloitte
Baxter
Daiichi Sankyo
Julphar
Cerilliant

Generated: July 18, 2018

DrugPatentWatch Database Preview

Aspirin; caffeine; orphenadrine citrate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for aspirin; caffeine; orphenadrine citrate and what is the scope of aspirin; caffeine; orphenadrine citrate freedom to operate?

Aspirin; caffeine; orphenadrine citrate
is the generic ingredient in seven branded drugs marketed by Sandoz, Medicis, Stevens J, and Galt Pharms, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for aspirin; caffeine; orphenadrine citrate. One supplier is listed for this compound.
Summary for aspirin; caffeine; orphenadrine citrate
US Patents:0
Tradenames:7
Applicants:4
NDAs:5
Drug Master File Entries: 21
Suppliers / Packagers: 1
DailyMed Link:aspirin; caffeine; orphenadrine citrate at DailyMed

US Patents and Regulatory Information for aspirin; caffeine; orphenadrine citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galt Pharms ORPHENGESIC FORTE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 075141-002 May 29, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Medicis NORGESIC aspirin; caffeine; orphenadrine citrate TABLET;ORAL 013416-003 Oct 27, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz INVAGESIC FORTE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 074817-002 Nov 27, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Medicis NORGESIC FORTE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 013416-004 Oct 27, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Citi
Dow
Express Scripts
Merck
US Army
Harvard Business School
UBS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.